Application of a metatranscriptomics technology, CSI-Dx, for the detection of pathogens associated with prosthetic

Justin R Wright1, Jeremy R Chen See1, Truc T Ly1

  • 1Contamination Source Identification, 419 14th St., Huntingdon, PA, 16652, USA.

Scientific Reports
|October 23, 2024
PubMed

Insights

A new metatranscriptomic (MT) workflow, CSI-Dx, shows promise for diagnosing prosthetic joint infections by identifying active pathogens. This method offers improved sensitivity over traditional cultures, detecting both culturable and non-culturable microbes.

Area of Science:

  • Microbiology
  • Genomics
  • Infectious Diseases

Background:

  • Accurate preoperative identification of pathogens is essential for prosthetic joint infection (PJI) treatment.
  • Current diagnostic methods like culture-based techniques have limitations in sensitivity and scope.
  • Metatranscriptomics (MT) offers a way to study transcriptionally active microbes, providing deeper insights than traditional methods.

Purpose of the Study:

  • To evaluate the clinical utility of a novel metatranscriptomic workflow, CSI-Dx, for detecting pathogens in prosthetic joint infections.
  • To compare the performance of CSI-Dx against traditional culture-based methods using human synovial fluid specimens.
  • To assess the potential of MT for identifying both culturable and non-culturable microorganisms and detecting antimicrobial resistance genes.

Main Methods:

  • A cohort of 340 human synovial fluid samples from patients with suspected PJI was analyzed.
  • Samples were subjected to both the novel CSI-Dx metatranscriptomic workflow and traditional culture-based diagnostic methods.
  • Exploratory analyses focused on determining the sensitivity and specificity of CSI-Dx for identifying key microbial taxa.

Main Results:

  • The CSI-Dx workflow provided insights into the active microbial community composition in synovial fluid from arthroplasty patients.
  • The study demonstrated the potential clinical utility of CSI-Dx in aiding PJI diagnosis.
  • CSI-Dx showed potential for improved sensitivity and acceptable specificity compared to synovial fluid culture, detecting a broader range of microorganisms.

Conclusions:

  • Metatranscriptomic technology like CSI-Dx can offer a comprehensive view of pathogens associated with PJI.
  • CSI-Dx provides valuable information on antimicrobial resistance gene expression.
  • Integrating MT into clinical practice could revolutionize PJI diagnosis by offering a more complete and active picture of the infection.